Zhang Y - Search Results

1

MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.

Fu F, Wan X, Wang D, Kong Z, Zhang Y, Huang W, Wang C, Wu H, Li Y. Fu F, et al. Among authors: zhang y. Oncotarget. 2017 Dec 6;9(2):1931-1943. doi: 10.18632/oncotarget.23026. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416742 Free PMC article.

2

Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.

Wan X, Pu H, Huang W, Yang S, Zhang Y, Kong Z, Yang Z, Zhao P, Li A, Li T, Li Y. Wan X, et al. Among authors: zhang y. Oncotarget. 2016 Aug 9;7(32):51284-51300. doi: 10.18632/oncotarget.9992. Oncotarget. 2016. PMID: 27323416 Free PMC article.

3

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.

Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu F, Huang Y, Wu H, Li T, Li Y. Wan X, et al. Among authors: zhang y. Oncotarget. 2016 Sep 13;7(37):60503-60518. doi: 10.18632/oncotarget.11391. Oncotarget. 2016. PMID: 27556357 Free PMC article.

4

A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.

Meng D, Yang S, Wan X, Zhang Y, Huang W, Zhao P, Li T, Wang L, Huang Y, Li T, Li Y. Meng D, et al. Among authors: zhang y. Int J Biochem Cell Biol. 2016 Apr;73:30-40. doi: 10.1016/j.biocel.2016.01.018. Epub 2016 Jan 28. Int J Biochem Cell Biol. 2016. PMID: 26827675

5

Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.

Zhang Y, Zhang P, Wan X, Su X, Kong Z, Zhai Q, Xiang X, Li L, Li Y. Zhang Y, et al. Among authors: zhang p. Biomed Pharmacother. 2016 Oct;83:936-941. doi: 10.1016/j.biopha.2016.08.013. Epub 2016 Aug 11. Biomed Pharmacother. 2016. PMID: 27522256

6

Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.

Wan X, Huang W, Yang S, Zhang Y, Zhang P, Kong Z, Li T, Wu H, Jing F, Li Y. Wan X, et al. Among authors: zhang p, zhang y. Int J Biochem Cell Biol. 2016 Oct;79:249-260. doi: 10.1016/j.biocel.2016.08.043. Epub 2016 Sep 1. Int J Biochem Cell Biol. 2016. PMID: 27594411

7

Increased expression of long non-coding RNA GLIDR in prostate cancer.

Zhang Y, Kong Z, Zhang Y, Huang W, Wu H, Wan X, Li Y. Zhang Y, et al. Cancer Biomark. 2017;19(2):145-150. doi: 10.3233/CBM-160166. Cancer Biomark. 2017. PMID: 28211799

8

Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer.

Kong Z, Wan X, Zhang Y, Zhang P, Zhang Y, Zhang X, Qi X, Wu H, Huang J, Li Y. Kong Z, et al. Among authors: zhang p, zhang x, zhang y. Biochem Biophys Res Commun. 2017 Nov 25;493(3):1217-1223. doi: 10.1016/j.bbrc.2017.07.162. Epub 2017 Jul 29. Biochem Biophys Res Commun. 2017. PMID: 28765045

9

Androgen-responsive lncRNA LINC00304 promotes cell cycle and proliferation via regulating CCNA1.

Zhang P, Lu Y, Kong Z, Zhang Y, Fu F, Su X, Huang Y, Wan X, Li Y. Zhang P, et al. Among authors: zhang y. Prostate. 2019 Jun;79(9):994-1006. doi: 10.1002/pros.23811. Epub 2019 Apr 23. Prostate. 2019. PMID: 31012142

10

A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.

Wang D, Wan X, Zhang Y, Kong Z, Lu Y, Sun X, Huang Y, Ji C, Li D, Luo J, Gu W, Wang C, Li Y, Xu Y. Wang D, et al. Among authors: zhang y. Prostate. 2019 Sep;79(12):1362-1377. doi: 10.1002/pros.23840. Epub 2019 Jul 3. Prostate. 2019. PMID: 31269242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262,005 results

Search Page

Filters